New Search

If you are not happy with the results below please do another search

Search
Generic filters

50 search results for:

1

Octapharma Uses IVIG as Potential Treatment for Covid-19

Intravenous immunoglobulin (IVIG) could be a key to combating seriously ill Covid-19 patients who have been hospitalized due to complications from the disease, and Octapharma AG aims to find out as the company assesses the plasma-based treatment in a Phase III study.

4

Novavax and SIPL to Develop 1 Billion Covid-19 Vaccine Doses for India, Other Countries

Days after reports of Novavax Inc.’s experimental Covid-19 vaccine candidate producing antibodies in healthy patients in a clinical study, the company announced a license agreement with Serum Institute of India Private Limited (SIPL) to develop up to 1 billion doses of the preventative drug in India and other countries.